Aesthetic Plastic Surgery

, Volume 37, Issue 4, pp 767–769 | Cite as

Mondor’s Subcutaneous Banding After Transaxillary Breast Augmentation: Case Report and the Review of Literature

  • Igor NiechajevEmail author
Case Report Breast


Mondor’s disease is a rare benign condition characterized by the formation of subcutaneous bands or strings in various locations, generally assumed to be symptoms of thrombophlebitis or phlebitis of the subcutaneous veins. Some findings, however, point toward a lymphatic origin of the bands. More biopsies of the cord and histologic studies are necessary to resolve this dispute. The chest, abdominal wall, penis, upper inner arm, and other regions of the body can be affected. The pathophysiology is unclear, but trauma of some kind, such as transsection during surgery or external compression, probably triggers its development. Mondor’s thrombophlebitis occurs in 12 % of breast cancer patients. Typically, there is an abrupt onset of tenderness and pain in the affected area a few weeks or months after breast surgery. The disease course is self-limiting, lasting weeks or, on rare occasions, months before spontaneously resolving. Usually, no treatment is necessary, but sometimes a topical nonsteroid antiinflammatory ointment is given. The majority of reports describe thrombophlebitis on the thoracoabdominal wall as a sequela of breast surgery. Mondor’s bowstring cord on the upper inner arm after previous transaxillary breast augmentation is rarely reported in the literature and less known. This report is intended to update our knowledge on this possible complication, which may cause unnecessary distress to the patient and the treating physician.

Level of Evidence V

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors


Breast surgery Mondor’s disease Phlebitis Subcutaneous banding Thrombophlebitis Transaxillary breast augmentation 



The author has no financial interest in any of the medical companies mentioned in this article. He has lectured in several courses and symposia organized by the Eurosilicone Ltd. and has received lecturer fees. He has no stocks and holds no appointed position with any medical firm.


  1. 1.
    Catania S, Zurrida S, Veronesi P, Galimberti V, Bona A, Pluchinotta A (1992) Mondor disease and breast cancer. Cancer 69:2267–2270PubMedCrossRefGoogle Scholar
  2. 2.
    Coscia J, Lance S, Wong M, Garcia J (2012) Mondor’s thrombophlebitis 13 years after breast augmentation. Ann Plast Surg 68:336–337PubMedCrossRefGoogle Scholar
  3. 3.
    Dowden RV (1997) Subcutaneous fibrous banding after transaxillary subpectoral endoscopic breast augmentation. Plast Reconstr Surg 99:257PubMedGoogle Scholar
  4. 4.
    Elsahy NI (1983) Recurrent Mondor’s disease after augmentation mammoplasty. Aesthetic Plast Surg 7:259–260PubMedCrossRefGoogle Scholar
  5. 5.
    Fagge C (1869) Remarks on certain cutaneous affections. Guy’s Hosp Rep 15:295–364Google Scholar
  6. 6.
    Hacker SM (1994) Axillary string phlebitis in pregnancy: a variant of Mondor’s disease. J Am Acad Dermatol 30:636–638PubMedCrossRefGoogle Scholar
  7. 7.
    Khan UD (2008) Incidence of Mondor disease in breast augmentation: a retrospective study of 2,052 breasts using inframammary incision. Plast Reconstr Surg 122:88e–89ePubMedCrossRefGoogle Scholar
  8. 8.
    Loos B, Horch RE (2006) Mondor’s disease after breast reduction surgery. Plast Reconstr Surg 117:129e–132ePubMedCrossRefGoogle Scholar
  9. 9.
    Marsch WCh, Haas N, Stüttgen G (1986) “Mondor’s phlebitis”—a lymphovascular process. Light and electron microscopic indications. Dermatologica 172:133–138PubMedCrossRefGoogle Scholar
  10. 10.
    Martin-Bertolin S, Gonzalez-Martinez R, Velasco-Pastor M, del Pinio Gil-Mateo M, Amorrortu-Velayos J (1995) Mondor’s disease and aesthetic breast surgery: report of case secondary to mastopexy with augmentation. Aesthetic Plast Surg 19:251–252CrossRefGoogle Scholar
  11. 11.
    Maximovich SP (1996) Transient axillary-upper inner arm subcutaneous fibrous banding following transaxillary subpectoral endoscopic breast augmentation. Plast Reconstr Surg 97:1304PubMedCrossRefGoogle Scholar
  12. 12.
    Maximovich SP (1997) Transient axillary-upper arm subcutaneous fibrous banding (reply). Plast Reconstr Surg 98:596Google Scholar
  13. 13.
    Mondor H (1939) Tronculite sous-cutanee subaique de la paroi thoracique antero-laterale. Mem Acad Chir 1271–1278Google Scholar
  14. 14.
    Niechajev I (2001) Mammary augmentation by cohesive silicone gel implants with anatomic shape: technical considerations. Aesthetic Plast Surg 25:397–403PubMedCrossRefGoogle Scholar
  15. 15.
    Niechajev I, Jurell G, Lohjelm L (2007) Prospective study comparing two brands cohesive gel implants with anatomic shape: 5-year follow-up evaluation. Aesthetic Plast Surg 31:697–710PubMedCrossRefGoogle Scholar
  16. 16.
    Niechajev I (2010) Improvements in transaxillary breast augmentation. Aesthetic Plast Surg 34:322–329PubMedCrossRefGoogle Scholar
  17. 17.
    Schiffman MA (1997) Transient axillary upper arm subcutaneous fibrous banding. Plast Reconstr Surg 98:596Google Scholar
  18. 18.
    Viana GA, Okano FM (2008) Superficial thrombophlebitis (Mondor’s disease) after breast augmentation surgery. Indian J Plast Surg 41:219–221PubMedCrossRefGoogle Scholar
  19. 19.
    Young RY (1997) Transaxillary submuscular breast augmentation and subcutaneous fibrous bands. Plast Reconstr Surg 99:257PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York and International Society of Aesthetic Plastic Surgery 2013

Authors and Affiliations

  1. 1.Lidingö-clinicLidingö-StockholmSweden

Personalised recommendations